12 | Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
06/2015
-
01/2002 |
11 | Sunitinib (Sutent)FDA Link
06/2015
-
01/2003 |
9 | Phosphotransferases (Kinase)IBA
07/2006
-
03/2002 |
7 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2006
-
01/2002 |
5 | Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
07/2006
-
01/2002 |
5 | Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
07/2006
-
01/2002 |
4 | Semaxinib (SU5416)IBA
07/2004
-
01/2002 |
4 | Tyrosine Kinase InhibitorsIBA
02/2004
-
01/2003 |
4 | orantinib (SU6668)IBA
08/2003
-
01/2002 |
3 | LigandsIBA
07/2006
-
07/2002 |
3 | tyrosine receptor (receptor, tyrosine)IBA
07/2006
-
07/2004 |
3 | Proteins (Proteins, Gene)FDA Link
07/2006
-
11/2003 |
2 | Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2006
-
08/2003 |
2 | Docetaxel (Taxotere)FDA Link
07/2006
-
10/2003 |
2 | fms-Like Tyrosine Kinase 3IBA
07/2006
-
10/2002 |
2 | Platelet-Derived Growth FactorIBA
05/2006
-
03/2002 |
2 | Imatinib Mesylate (Gleevec)FDA Link
05/2006
-
05/2003 |
2 | Biomarkers (Surrogate Marker)IBA
02/2004
-
02/2003 |
2 | toceranib phosphateIBA
11/2003
-
07/2003 |
2 | STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
11/2003
-
05/2003 |
2 | Focal Adhesion Protein-Tyrosine KinasesIBA
11/2003
-
05/2003 |
2 | Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
08/2003
-
01/2002 |
2 | OxindolesIBA
07/2003
-
05/2003 |
2 | Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2002
-
01/2002 |
1 | Dipeptidyl-Peptidase IV InhibitorsIBA
08/2007 |
1 | Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
07/2006 |
1 | 5- ((5- fluoro- 2- oxo- 1,2- dihydro- 3H- indol- 3- ylidene)methyl)- N- (2- hydroxy- 3- morpholin- 4- ylpropyl)- 2,4- dimethyl- 1H- pyrrole- 3- carboxamideIBA
07/2006 |
1 | Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
07/2006 |
1 | 3- (5- methyl- 2- (2- oxo- 1,2- dihydroindol- 3- ylidenemethyl)- 1H- pyrrol- 3- yl)propionic acidIBA
05/2006 |
1 | Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
12/2004 |
1 | osteoblast cadherinIBA
02/2004 |
1 | Proto-Oncogene Proteins c-metIBA
11/2003 |
1 | Adenosine Triphosphate (ATP)IBA
11/2003 |
1 | Phospholipase C gammaIBA
11/2003 |
1 | Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
11/2003 |
1 | 5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA
11/2003 |
1 | Fluorouracil (Carac)FDA LinkGeneric
10/2003 |
1 | Doxorubicin (Adriamycin)FDA LinkGeneric
10/2003 |
1 | Cytotoxins (Cytolysins)IBA
10/2003 |
1 | Paclitaxel (Taxol)FDA LinkGeneric
08/2003 |
1 | Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
08/2003 |
1 | Antineoplastic Agents (Antineoplastics)IBA
07/2003 |
1 | Cisplatin (Platino)FDA LinkGeneric
05/2003 |
1 | PlatinumIBA
05/2003 |
1 | AgarIBA
05/2003 |
1 | src-Family KinasesIBA
05/2003 |
1 | EpitopesIBA
05/2003 |
1 | Macrophage Colony-Stimulating FactorIBA
01/2003 |
1 | Tyrosine (L-Tyrosine)FDA Link
01/2003 |
1 | Dihydrotachysterol (AT 10)IBA
01/2003 |
1 | pyridinolineIBA
01/2003 |
1 | Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
03/2002 |